0001728411-21-000002.txt : 20211210
0001728411-21-000002.hdr.sgml : 20211210
20211210144752
ACCESSION NUMBER: 0001728411-21-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20211210
DATE AS OF CHANGE: 20211210
EFFECTIVENESS DATE: 20211210
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: DMC Biotechnologies, Inc.
CENTRAL INDEX KEY: 0001728411
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-424544
FILM NUMBER: 211484910
BUSINESS ADDRESS:
STREET 1: 5333 EUCLID AVENUE
CITY: BOULDER
STATE: CO
ZIP: 80303
BUSINESS PHONE: (303) 210-2829
MAIL ADDRESS:
STREET 1: 5333 EUCLID AVENUE
CITY: BOULDER
STATE: CO
ZIP: 80303
D
1
primary_doc.xml
X0708
D
LIVE
0001728411
DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
720-239-7239
DELAWARE
None
None
Corporation
true
2017
Matthew
Lipscomb
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Executive Officer
Director
Michael
D.
Lynch
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Director
Carolyn
Fritz
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Director
Rob
van der Meij
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Director
Josko
Bobanovic
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Director
Doug
Cameron
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Director
Alastair
Cooper
c/o DMC Biotechnologies, Inc.
2477 55th Street, Suite 120
Boulder
CO
COLORADO
80301
Director
Biotechnology
Decline to Disclose
- 06b
false
2021-11-30
false
true
false
0
43500000
33760493
9739507
The Total Offering Amount and Total Amount Sold includes equity issued upon the conversion of outstanding principal and interest of convertible promissory notes.
false
12
0
0
0
false
DMC Biotechnologies, Inc.
/s/ Matthew Lipscomb
Matthew Lipscomb
Chief Executive Officer
2021-12-10